Molecular biology of hepatitis D virus: Research and potential for application

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 9-10, 1997, Pages

  Chen, Pei Jer ^a   Wu, Hui Lin ^a   Wang, Chuan Jen ^a   Chia, Ju Hsin ^a   Chen, Ding Shinn ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

DNA vaccine; Hepatitis D virus; Protein modification; Ribozyme; Vaccine; Yeast

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC G 418; CEFOPERAZONE; DNA VACCINE; GENTAMICIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS DELTA ANTIGEN; INTERFERON; KANAMYCIN; NEOMYCIN; NETILMICIN; PHOSPHOPROTEIN; RIBOZYME; STREPTOMYCIN; TOBRAMYCIN; VIRUS RNA;

CONFERENCE PAPER; DELTA AGENT HEPATITIS; HEPATITIS DELTA VIRUS; HUMAN; ISOPRENYLATION; LIVER CIRRHOSIS; MEDICAL RESEARCH; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; SUPERINFECTION; VIRUS ASSEMBLY; VIRUS CARRIER; VIRUS REPLICATION;

EID: 84984569930     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00500.x     Document Type: Conference Paper

References (17)

1. Carreno V, Bartolome J, Modejon A. Hepatitis delta virus infection: Molecular biology and treatment. Dig. Dis. 1994; 12: 265-75.
2. Wu JC, Chen TZ, Huang YS et al. Natural history of hepatitis D viral superinfection: Significance of viremia detected by polymerase chain reaction. Gastroenterology 1995; 108: 796-802.
3. Farci P, Mandas A, Coina A et al. Treatment of hepatitis D with interferon alfa-2a. N. Engl. J. Med. 1994; 330: 88-94.
4. Modejon A, Cotonat T, Bartolome J, Castillo I, Carreno V. Treatment of chronic hepatitis D with low and high doses of interferon-alpha 2a: Utility of polymerase chain reaction in monitoring antiviral response. Hepatology 1994; 19: 1331-6.
5. Lai MMC. The molecular biology of hepatitis D virus. Annu. Rev. Biochem. 1995; 64: 259-86.
6. Yeh TS, Lo SZ, Chen PJ, Wu-Lee YH. Casein kinase II and protein kinase C modulate hepatitis delta virus RNA replication but not empty viral particle assembly. J. Virol. 1996; 70: 6190-8.
7. Davies J, von Ahsen U, Schoeder R. The RNA world. In: Gesteland RF, Atkins JF, eds. Davies J. Antibiotics and the RNA world: A role for low-molecular veight effectors in biochemical evolution? New York: Cold Spring Harbor Laboratory Press, Chapter 8, 1993; 185-204.
8. Wu HN, Lin YJ, Lin FP, Makino S, Chang MF, Lai MMC. Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc. Natl Acad. Sci. USA 1989; 86: 1831-5.
9. Chia JS. Inhibition of hepatitis D virus genomic ribozyme by aminoglycosides. Masters Thesis, National Taiwan University, Taiwan. 1995.
10. Rogers J, Chang AH, von Ashen U, Schroeder R, Davies J. Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics. J. Mol. Biol. 1996; 259: 916-25.
11. Glenn J. Prenylation and virion morphogenesis. In: Gail Dinter-Gottlieb, ed. The Unique Hepatitis Delta Virus. Austin: RG Landes Company.
12. Wang CJ, Subg SY, Chen DS, Chen PJ. N-linked glycosylation of hepatitis B surface antigen is involved but not essential in the assembly of hepatitis delta virus. Virology 1996; 220: 28-36.
13. Eckart MR, Dong C, Houghton M, Dæ Urso N, Ponzetto A. The effects of using recombinant vaccinia viruses expressing either large or small HDAg to protect woodchuck hepadnavirus carriers from HDV superinfection. Progr. Clin. Biol. Res. 1993; 382: 201-5.
14. Ulmer JB, Donnelly JJ, Parker SE et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259: 1754-9.
15. Polo JM, Lim B, Govindarajan S, Lai MMC. Replication of hepatitis delta virus RNA in mice after intramuscular injection of plasmid DNA. J. Virol. 1995; 69: 5203-7.
16. Ryu WS, Bayer M, Taylor JM. Assembly of hepatitis delta virus particles. J. Virol 1992; 66: 2310-15.
17. Wu HL, Chen PJ, Kao TL, Chi WK, Chen DS. Assembly of empty hepatitis delta virus-like particles in the yeast. (in press).